AIHP’s Nominations Committee has released a slate of proposed officers and directors to stand for election to the Board of Directors in 2019. AIHP’s bylaws provide that additional nominations may be made at the Annual Business Meeting, to be held November 15, 2019, by any individual member in attendance if seconded by two additional members. After nominations are finalized, an election by members will be conducted in 2019, and those elected will be installed at the 2019 Annual Business Meeting.
The Committee has nominated the following members:
- For President (Two-Year Term, 2020-2021): W. Clarke Ridgway.
- For Vice President (Three-Year Term, 2020-2022): John Grabenstein.
- For Secretary (One-Year Term, 2020): Robert Buerki.
- For Board Member At-Large (Three-Year Term, 2020-2022): Arthur Daemmrich.
-
For Board Member At-Large (One-Year Term, 2020): Catherine Taglieri.
Biographies of the nominees appear at the end of this article.
The staggered terms for nominees are the result of bylaw changes approved in 2016. From 2003 until 2016, AIHP officers (President, Vice President, Secretary, Treasurer) and two At-Large Board Members were elected by AIHP membership to two-year terms. The revised bylaws call for the President, Vice President, and Secretary to be elected to staggered three-year terms, and for three At-Large Board Members to also be elected to staggered three-year terms. Because AIHP officers had already been nominated to run for a two-year term (2018 and 2019) in the 2017 election, the new bylaws did not immediately take effect. With these two-year terms expiring, AIHP will be transitioning to three-year staggered terms for the officers and adding a third elected At-Large Member. (In the recently-concluded 2018 Board election, Angela Long was reelected to a three-year At-Large Board position for 2019-2021.)
The Nominating Committee’s slate will be formally presented at the November 15, 2018 Annual Business Meeting. Additional nominations may be made at that time. Click here for more information about the upcoming Annual Business Meeting.
AIHP members William Zellmer, Jeanine Mount, and John Swann serve on the Nominating Committee. AIHP Executive Director Greg Higby is an ex officio member of the Committee.
Biographies of proposed slate of AIHP officers and directors for 2019 election:
W. Clarke Ridgway, BS Pharmacy, is the nominee for President. Mr. Ridgway is a native of Wheeling, WV. He received a B.S. in Pharmacy from West Virginia University in 1971, has practice experiences in retail, hospital, clinic and geriatric settings and spent 32 years in pharmacy education. Teaching experiences include history of pharmacy, geriatrics, ethics, professional development, pharmacy museum and artifacts and laboratory courses. He received the AIHP Teaching Improvement Award in 1985 and retired as Assistant Dean for Student Services, West Virginia University School of Pharmacy, where he continues as co-curator of the Cook-Hayman Pharmacy Museum.
Mr. Ridgway has served as AIHP Treasurer since 2011 and has also been a member of numerous committees, the Director’s Advisory Panel, and Council President. Research interests include the history of pharmacy practice, antebellum and Civil War pharmacy and medicine, and the history of home remedies.
John Grabenstein, RPh, PhD, is the nominee for Vice President. Dr. Grabenstein is Global Director of Medical Affairs for Merck Vaccines. He leads medical-affairs and scientific-policy activities for Merck’s global vaccine enterprise that provides 150 million doses annually for 12 vaccines. A pharmacist, he has experience in over 50 countries, served on multiple committees advising the U.S. Government, and published over 400 articles and nine books, primarily on topics of immunization, public health, and leadership.
Previously, as a Colonel in the U.S. Army, Dr. Grabenstein directed the Military Vaccine Agency and he oversaw the Defense Department immunization programs for 9 million troops, retirees, and family members spread across 4 continents and dozens of ships at sea.
Dr. Grabenstein, who currently serves on AIHP’s Board of Directors, received his pharmacy degree from Duquesne University in 1980, a master’s degree in education from Boston University in 1988, and his doctorate in epidemiology at the University of North Carolina in 1999.
Robert Buerki, PhD, RPh, is the nominee for Secretary. Dr. Buerki is Professor-Emeritus at The Ohio State University College of Pharmacy, where he has taught the history of pharmacy and professional ethics for many years. He received a B.S. in Pharmacy and a M.S. in Social Studies in Pharmacy from the University of Wisconsin-Madison. He earned a Ph.D. from The Ohio State University.
Dr. Buerki has published dozens of peer-reviewed articles in the areas of professional ethics and pharmacy history and education. He is also the author of several books, including Ethical Responsibility in Pharmacy Practice (with Louis D. Vottero) (AIHP, 2002) and Foundations of Ethical Pharmacy Practice (with Louis D. Vottero) (AIHP, 2008). He has been inducted into the International Academy of the History of Pharmacy and is the 2004 recipient of AIHP’s Edward Kremers Award.
Dr. Buerki has been a member of AIHP since 1963 and served as its President from 1983-85. He has served as AIHP’s Secretary since 2005.
Arthur Daemmrich, PhD, is being nominated for a three-year term as an At-Large Director. Dr. Daemmrich is Director of the Smithsonian Institution’s Lemelson Center for the Study of Invention and Innovation at the National Museum of American History. He previously was an associate professor in the Department of History and Philosophy of Medicine at the University of Kansas School of Medicine, an assistant professor at Harvard Business School, and a visiting professor at the China Europe International Business School.
Dr. Daemmrich’s scholarly work analyzes the emergence of technology-based industries, explores the relationship between regulation and innovation, and compares innovation systems internationally. Daemmrich has published in the history of medicine, science and technology studies, and health policy, including the monograph, Pharmacopolitics: Drug Regulation in the United States and Germany, and 50 peer-reviewed articles, books chapters, and teaching cases used worldwide.
Dr. Daemmrich has served as AIHP’s Vice President since 2016.
Catherine Taglieri, PharmD, RPh, is being nominated for a one-year term as an At-Large Director. Professor Taglieri is a licensed pharmacist and Associate Professor of Pharmacy Practice at MCPHS University (formerly known as the Massachusetts College of Pharmacy and Health Sciences). She has practiced in a variety of pharmacy settings, including community, consulting and long-term care. She received both a B.S. in Pharmacy and a PharmD from MCPHS University. Professor Taglieri currently serves on AIHP’s Board of Directors.
For the past ten years, Prof. Taglieri has served as one of the faculty coordinators for the Introductory and Advanced Practice courses and pharmacy skills labs for MCPHS University. In 2018, she was awarded the Trustee’s Award for teaching excellence. Her area of research is primarily in the scholarship of teaching and learning, but she also has published abstracts and brief articles in the field of pharmaceutics and the history of pharmacy. She currently serves as the Editor for the AACP’s History of Pharmacy Special Interest Group (SIG) Newsletter and previously served as Secretary of the SIG.
The American Institute of the History of Pharmacy is documenting and preserving pharmacy stories and experiences during the COVID-19 global pandemic for the benefit of future historians and scholars. We seek to record the effects of this public health emergency on all types of pharmacy experiences. We invite you to share your pharmacy stories, photos, videos, artifacts, and other documentation of the COVID-19 coronavirus pandemic.